LEARN — PHARMACOKINETICS BASICS
What is Drug Half-Life? A Complete Guide
A pharmacist-written explanation of t½ — from the basic definition to clinical significance, with real-world examples and a reference table of common medications.
Written by Jay, Licensed Pharmacist
March 8, 2026 · Reviewed for clinical accuracy
When your doctor says "take this every 6 hours," have you ever wondered why it's not every 5 hours, or every 12? When a pharmacist tells you that you need to wait two weeks after stopping one antidepressant before starting another, why exactly two weeks? And why does a single cup of coffee keep some people wired until midnight while others can sleep perfectly after an espresso at 9pm?
The answer to all of these questions comes back to the same concept: drug half-life. It is one of the most important ideas in pharmacology, and once you understand it, a surprising amount of how medications work — and why they are prescribed the way they are — will suddenly make intuitive sense.
What is drug half-life (t½)?
The elimination half-life of a drug, written as t½, is the time it takes for the concentration of that drug in your bloodstream to fall by exactly 50%. Put simply: if you have 200 mg of a drug with a 4-hour half-life in your system right now, you will have 100 mg remaining in 4 hours, 50 mg in 8 hours, 25 mg in 12 hours, and so on.
The word "elimination" is key. Half-life describes how quickly the body removes a drug — not how quickly it works. A drug can start working within minutes while taking days to fully clear your system, or it can take hours to reach peak effect but clear relatively quickly. Half-life and onset of action are independent properties.
It is also worth noting that half-life specifically refers to the concentration in plasma (the liquid component of blood), which is used as a proxy for drug concentration throughout the body. Measuring plasma concentration is practical and reproducible, making it the standard reference point in pharmacokinetics.
The mathematics behind it
Most drugs follow what pharmacologists call first-order elimination kinetics. This means the rate at which the drug is removed from your body is directly proportional to the current concentration — the more drug present, the faster it is eliminated. As the concentration falls, elimination slows proportionally. This relationship produces a smooth exponential decay curve.
The mathematical relationship is expressed using the elimination rate constant (ke):
ke = ln(2) / t½ ≈ 0.693 / t½
C(t) = C₀ × e−ket
Where C₀ is the initial drug concentration and C(t) is the concentration at time t. The natural logarithm of 2 (ln 2 ≈ 0.693) appears because you are solving for the point at which exactly half the drug remains.
You do not need to memorize these equations to understand half-life. The key insight is that elimination is always a fixed fraction of whatever is left, not a fixed amount. This is what makes it exponential: each half-life removes exactly 50% of the remaining drug, regardless of whether that is 1,000 mg or 1 mg.
A real-world walkthrough: caffeine
Caffeine has an average half-life of about 5 hours in healthy adults, though it can range from 3 to 7 hours depending on individual factors (more on those below). Let us trace a typical morning coffee scenario step by step. You drink a large coffee at 8:00 AM, delivering approximately 200 mg of caffeine.
Notice that even at 11:00 PM — 15 hours after your morning coffee — there is still 25 mg of caffeine in your system. That is roughly equivalent to a quarter cup of coffee. For someone who is sensitive to caffeine's stimulant effects, this residual amount can meaningfully disrupt sleep quality. This is not hypothetical; multiple studies have confirmed that caffeine consumed 6 hours before bedtime reduces total sleep time by an average of one hour.
Why half-life matters in practice
Dosing frequency
Half-life is the primary driver behind how often a drug needs to be taken. As a general rule, a drug is dosed at intervals of one to two half-lives to maintain plasma concentrations within the therapeutic window — the range where the drug is effective without being toxic. Ibuprofen, with its 2-hour half-life, must be taken every 4–6 hours to sustain anti-inflammatory effects. Fluoxetine (Prozac), with a half-life of 1 to 6 days, can maintain adequate plasma levels with a single daily dose — and actually remains detectable in the body for weeks after the last tablet.
Time to full elimination
A drug is considered essentially eliminated after 5 to 7 half-lives. At that point, less than 1–3% of the original dose remains — a pharmacologically insignificant amount for most drugs. This means a drug with a 6-hour half-life clears your system in roughly 30–42 hours. A drug with a 5-day half-life takes 25 to 35 days. This rule of thumb has enormous clinical relevance: it determines washout periods before switching medications, guides drug testing timelines, and informs how long a drug's effects (and side effects) will persist after stopping.
Drug interactions involving half-life
Many drug interactions work by changing a drug's half-life. When one drug inhibits the liver enzymes that metabolize another, clearance slows and the half-life effectively lengthens — causing the drug to accumulate to higher-than-intended concentrations. Conversely, enzyme inducers speed up metabolism, shorten effective half-life, and may reduce a drug's efficacy. Fluconazole, for instance, inhibits CYP2C9 and can more than double the half-life of warfarin, dramatically increasing bleeding risk.
Factors that alter drug half-life
The half-life values quoted in drug references are population averages. In real patients, they can vary substantially — sometimes by a factor of 5 to 10 — due to the following variables.
Age
Neonates (newborns) have immature liver enzyme systems and underdeveloped renal function, dramatically prolonging the half-life of many drugs. Chloramphenicol, for example, has a half-life of about 4 hours in adults but can exceed 24 hours in newborns — a difference that historically caused "grey baby syndrome" before neonatal dosing guidelines existed. At the other extreme, elderly patients typically show reduced hepatic blood flow, decreased enzyme activity, and lower glomerular filtration rates, all of which slow drug elimination and extend half-lives.
Liver function and CYP enzymes
The liver is the primary site of drug metabolism, and the cytochrome P450 (CYP) enzyme family does most of the heavy lifting. Liver disease — including cirrhosis, hepatitis, and liver failure — reduces both the quantity and activity of these enzymes. A drug that normally has a 4-hour half-life in a healthy liver might have a 12-hour or longer half-life in someone with severe hepatic impairment. This is why dose reductions are frequently required for liver-metabolized drugs in patients with hepatic disease.
Kidney function (renal clearance)
Many drugs — or their active metabolites — are excreted via the kidneys. Renal impairment slows this excretion and prolongs effective half-life. Drugs like digoxin, metformin, and most antibiotics require dose adjustment based on kidney function, typically measured as glomerular filtration rate (eGFR) or creatinine clearance (CrCl). Failure to adjust dosing in patients with renal disease is one of the most common causes of preventable drug toxicity.
Genetic polymorphisms (fast and slow metabolizers)
Genetic variation in CYP enzymes means that the same drug, at the same dose, can produce wildly different plasma concentrations in different people. CYP2D6 is a well-studied example: approximately 7–10% of Caucasians carry two loss-of-function alleles and are "poor metabolizers," meaning drugs metabolized by this enzyme accumulate to much higher levels. At the other end, "ultrarapid metabolizers" clear certain drugs so quickly that standard doses produce no therapeutic effect at all. Pharmacogenomic testing can now identify a patient's metabolizer status before prescribing, though this remains underutilized in routine clinical practice.
Drug interactions
Co-administered drugs can either inhibit or induce the enzymes responsible for clearing a particular drug. CYP inhibitors (fluconazole, ketoconazole, clarithromycin, grapefruit furanocoumarins) reduce metabolic clearance, extending half-life and raising drug levels. CYP inducers (rifampicin, carbamazepine, St John's Wort) do the opposite, accelerating clearance and potentially rendering a drug ineffective. The practical magnitude of these interactions ranges from trivial to life-threatening depending on the drug involved and the therapeutic index.
Clinical significance: beyond the basics
Drug accumulation with repeat dosing
When a drug is taken repeatedly before the previous dose has fully eliminated, drug concentrations build up — a phenomenon called accumulation. This is not dangerous by design; most dosing schedules intentionally cause accumulation up to a predictable plateau called steady state. The degree of accumulation depends directly on the ratio of dosing interval to half-life. A drug given every half-life accumulates to roughly double the single-dose concentration. Drugs given more frequently accumulate more.
Steady state
Steady state is reached when the amount of drug entering the body with each dose equals the amount being eliminated between doses. At steady state, plasma concentrations fluctuate predictably between a peak (Cmax) and trough (Cmin), but the average level remains constant. Steady state is reached after approximately 4 to 5 half-lives of continuous dosing, regardless of the dose size. This is why antidepressants — which have half-lives measured in days — take weeks to reach their therapeutic plateau, and why the full clinical effect of a new medication may not be apparent for some time after starting it.
Loading doses
For drugs with long half-lives where waiting 4–5 half-lives to reach therapeutic steady state is clinically unacceptable, a loading dose (or bolus) is used. By giving a larger initial dose, the prescriber rapidly achieves therapeutic plasma concentrations, then switches to a lower maintenance dose to sustain them. Digoxin, amiodarone, and vancomycin are classic examples where loading doses are routinely employed.
Washout periods
Before switching between certain medications, a washout period is required to allow the first drug to clear sufficiently. The most clinically critical example is the transition between MAO inhibitors (MAOIs) and SSRIs: combining them can cause a life-threatening serotonin syndrome. Fluoxetine, with its 1 to 6-day half-life plus an active metabolite (norfluoxetine) with a 4 to 16-day half-life, requires a 5-week washout before starting an MAOI. Understanding half-life makes these requirements logical rather than arbitrary.
Common drug half-lives at a glance
The following table lists typical half-lives for frequently encountered medications, based on values in healthy adults with normal organ function. Individual variation is expected.
Values represent typical ranges in healthy adults. Significant variation occurs with age, organ impairment, genetic polymorphisms, and drug interactions.
References & Further Reading
- Brunton LL, Knollmann BC, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw-Hill; 2023. Chapters 2–3 (Pharmacokinetics).
- Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 4th ed. Lippincott Williams & Wilkins; 2011.
- Winter ME. Basic Clinical Pharmacokinetics. 5th ed. Lippincott Williams & Wilkins; 2010.
- U.S. Food and Drug Administration. Individual drug prescribing information (package inserts) for referenced medications. Available at DailyMed (NIH).
- Benet LZ, Zia-Amirhosseini P. Basic principles of pharmacokinetics. Toxicol Pathol. 1995;23(2):115–123.
See half-life in action
The HalfLife simulator lets you choose any drug, set a dose and schedule, and watch the concentration-time curve build in real time. It is the fastest way to develop an intuitive feel for how half-life shapes drug behavior — especially with repeat dosing and steady state.
Open the Simulator →CONTINUE LEARNING
Medical disclaimer
This article is intended for educational purposes only and does not constitute medical advice. Drug half-life values are population averages and may differ significantly in individual patients due to age, organ function, genetics, and concurrent medications. Do not adjust your medication regimen based on information from this article. Always consult your pharmacist or physician for guidance specific to your clinical situation.